Nanjing Leads Biolabs (9887) Announces Extraordinary General Meeting on December 17, 2025

Bulletin Express11-28

Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has announced that an extraordinary general meeting (EGM) will take place on December 17, 2025, at 10:00 a.m. in Nanjing, PRC. The key items on the agenda include voting on the proposed adoption of an H Share Award Scheme, authorization to the board of directors and any appointed delegatee to handle matters related to this scheme, as well as consideration and approval of a service provider sublimit defined under the H Share Award Scheme.

In addition, the total number of newly allotted shares under the H Share Award Scheme would not exceed 5% of the company’s issued shares at the time of the EGM’s approval. Participants at the EGM will also address the proposed cancellation of the Supervisory Committee and amendments to the Articles of Association.

According to the announcement, the register of members of H shares closes from December 12, 2025, through December 17, 2025, and transfer documents must be lodged before 4:30 p.m. on December 11, 2025, to qualify for attendance. Further details and resolutions can be found in the official circular dated November 28, 2025, published on the websites of the Hong Kong Stock Exchange and the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment